Board approves preferential share swap to acquire Archit Life Science

Fund Raising View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-1.5%Reaction day

₹65.70

prior close

₹65.20

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.7%-2.2% vs market

Commodity Chemicals peers, median of 59sector+0.1%-1.6% vs sector

On the reaction day the stock moved 2.2 pts less than Nifty Microcap 250 and 1.6 pts less than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

+0.0

15m

+0.0

30m

+0.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-1.5+0.7-2.2+0.1-1.6

Next day

-1.3+1.1-2.4+1.2-2.5

+0.4+1.6-1.2+0.6-0.2

+2.0+1.5+0.5+1.3+0.7

-1.1+1.3-2.3-0.4-0.6

+3.3+1.4+2.0-0.2+3.6

+0.6-2.1+2.7-1.9+2.6

15d

-5.5-0.9-4.6-0.8-4.6

-4.9-1.4-3.4-2.8-2.1

—————

UpDownMarket · Nifty Microcap 250Sector · Commodity Chemicals peers, median of 59Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Board raised authorized capital from Rs 25 crore to Rs 60 crore. Also approved issuing 3.72 crore equity shares at Rs 65 each (Rs 10 face value, Rs 55 premium) via preferential share swap. This is to acquire 92.20 percent (1.86 crore shares) of Archit Life Science Limited at Rs 130 per share. Allottees include 44 entities from promoter and non-promoter groups. Subject to shareholder and regulatory approvals.

Likely market impact

Share swap acquisition will dilute existing holders but adds a new subsidiary. Promoter group stake will increase. No cash outflow.